Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 09, 2026

Dr Reddys Laboratories Ltd shares saw a -1.23% decrease, reaching a current market price of 1287.70. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.7100, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -1.23% drop, and it's now trading at 1287.70 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has dropped by -1.46%, a development that warrants careful analysis. Presently trading at 1284.80, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a -1.46% downturn in its share price, and it's currently trading at 1284.80. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -1.07% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1289.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.7100, while the industry PE is 32.4172.

Dr Reddys Laboratories Ltd share price has declined by -1.07%, and it's currently trading at 1289.90. The stock maintains a PE of 19.7100, while the industry PE is 32.4172, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd plunged by -1.10%, leaving investors concerned. At this moment, the stock can be acquired at 1289.50, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd plunged by -1.10%, leaving investors concerned. At this moment, the stock can be acquired at 1289.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd observed a -1.52% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1284.00. The stock has a PE ratio of 19.7100, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd has plummeted by -1.52%, signalling a challenging period. Currently trading at 1284.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd stock price decreased by -1.29%, with the current market value at 1287.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a -1.29% decrease, Dr Reddys Laboratories Ltd's share price is now 1287.00. Investors should examine the factors driving this decline. The stock's PE ratio is 19.7100, whereas the industry PE ratio stands at 32.4172.